Point72 Hong Kong LTD Amgen Inc Put Options Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.84 Million - $2.08 Million	-8,200 Reduced 57.75%	6,000 $1.35 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $5.31 Million - $5.91 Million	-23,000 Reduced 61.83%	14,200 $3.46 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $4.69 Million - $5.19 Million	21,400 Added 135.44%	37,200 $9 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $914,848 - $1.05 Million	4,600 Added 41.07%	15,800 $3.56 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $2.17 Million - $2.54 Million	-10,200 Reduced 47.66%	11,200 $2.38 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $3.83 Million - $4.25 Million	16,400 Added 328.0%	21,400 $5.22 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $1.11 Million - $1.29 Million	5,000 New	5,000 $1.24 Million

3,119

407M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.